YU64691A - Poboljšani ergolin-8-karboksamidi - Google Patents
Poboljšani ergolin-8-karboksamidiInfo
- Publication number
- YU64691A YU64691A YU64691A YU64691A YU64691A YU 64691 A YU64691 A YU 64691A YU 64691 A YU64691 A YU 64691A YU 64691 A YU64691 A YU 64691A YU 64691 A YU64691 A YU 64691A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- carboxamides
- ergolin
- improved
- provides
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J7/00—Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Power Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
POBOLJŠANI ERGOLIN-8-KARBOKSAMIDI, opisani su N-(2-hidroksiciklopentil)-1-izopropil-6-metilergolin-8-karboksamidi korisni za blokiranje 5HT2 receptora u sisara koji imaju višak serotonina centralno ili periferalno; metode za tretiranje seksualnih disfunkcija, hipertenzije, migrene, vazospazma, tromboze, ishemije, depresije, anksioznosti, poremećaja sna i poremećaja apetita sa jedinjenjem prema ovom pronalasku.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/508,324 US5043341A (en) | 1990-04-11 | 1990-04-11 | N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides |
Publications (2)
Publication Number | Publication Date |
---|---|
YU64691A true YU64691A (sh) | 1994-01-20 |
YU47809B YU47809B (sr) | 1996-01-09 |
Family
ID=24022297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU64691A YU47809B (sr) | 1990-04-11 | 1991-04-10 | Novi ergolin-8-karboksamidi i postupak za njihovo dobijanje |
Country Status (24)
Country | Link |
---|---|
US (1) | US5043341A (sh) |
EP (1) | EP0452074B1 (sh) |
JP (1) | JPH04224578A (sh) |
KR (1) | KR0165124B1 (sh) |
CN (1) | CN1038937C (sh) |
AT (1) | ATE133414T1 (sh) |
AU (1) | AU634374B2 (sh) |
CA (1) | CA2040170A1 (sh) |
CZ (1) | CZ279745B6 (sh) |
DE (1) | DE69116590T2 (sh) |
DK (1) | DK0452074T3 (sh) |
ES (1) | ES2082923T3 (sh) |
FI (1) | FI96604C (sh) |
GR (1) | GR3019416T3 (sh) |
HU (1) | HU206113B (sh) |
IE (1) | IE72084B1 (sh) |
IL (1) | IL97808A (sh) |
NO (1) | NO177709C (sh) |
NZ (1) | NZ237753A (sh) |
PT (1) | PT97299B (sh) |
RU (2) | RU2002746C1 (sh) |
TW (1) | TW199859B (sh) |
YU (1) | YU47809B (sh) |
ZA (1) | ZA912628B (sh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5141944A (en) * | 1990-04-11 | 1992-08-25 | Eli Lilly And Company | N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides |
JPH0613145U (ja) * | 1992-07-23 | 1994-02-18 | 日新電機株式会社 | 基板収納カセット |
US5441961A (en) * | 1992-08-27 | 1995-08-15 | Eli Lilly And Company | Substituted cyclo or bicycloalkylamides of (8β)-6-(substituted) ergolines |
US5516943A (en) * | 1993-09-14 | 1996-05-14 | Sepracor, Inc. | Process for preparing cyclic CIS-1-amino-2-alkanols |
US5599985A (en) * | 1993-09-14 | 1997-02-04 | Sepracor, Inc. | Optically pure 1-amido-2-indanols |
AU5317996A (en) * | 1995-04-18 | 1996-11-07 | Eli Lilly And Company | Method for using ergoline compounds to effect physiological and pathological functions at the 5-ht7 receptor |
US5880134A (en) * | 1996-03-20 | 1999-03-09 | Eli Lilly And Company | Method for using ergoline compounds to effect physiological and pathological functions at the 5-HT7 receptor |
US6385208B1 (en) * | 1998-06-02 | 2002-05-07 | Cisco Technology, Inc. | Serial media independent interface |
PT1401863E (pt) * | 2001-06-08 | 2009-07-23 | Ipsen Pharma | Análogos quiméricos da somatostatina-dopamina |
DE10212564B4 (de) * | 2002-03-12 | 2007-04-19 | Neurobiotec Gmbh | 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne |
GB0306604D0 (en) * | 2003-03-21 | 2003-04-30 | Curidium Ltd | Second medical use |
JP2005220081A (ja) * | 2004-02-06 | 2005-08-18 | Toray Fine Chemicals Co Ltd | cis−4−アミノ−1−ベンジル−3−ピロリジノールの製造方法およびピロリジン誘導体 |
WO2014070965A2 (en) | 2012-11-01 | 2014-05-08 | Ipsen Pharma S.A.S | Somatostatin analogs and dimers thereof |
TWI523863B (zh) | 2012-11-01 | 2016-03-01 | 艾普森藥品公司 | 體抑素-多巴胺嵌合體類似物 |
CA2891122C (en) | 2012-11-14 | 2021-07-20 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2997470A (en) * | 1956-03-05 | 1961-08-22 | Lilly Co Eli | Lysergic acid amides |
CA1339661C (en) * | 1987-06-15 | 1998-02-10 | Kathlenn Rose Whitten | Cycloalkylamides of (8b)-1alkyl-6 (substituted)ergolines |
US4931447A (en) * | 1987-06-15 | 1990-06-05 | Eli Lilly And Company | Cycloalkylamides of (8β)-1-alkyl-6-(substituted) ergolines |
-
1990
- 1990-04-11 US US07/508,324 patent/US5043341A/en not_active Expired - Fee Related
-
1991
- 1991-04-09 DE DE69116590T patent/DE69116590T2/de not_active Expired - Fee Related
- 1991-04-09 ZA ZA912628A patent/ZA912628B/xx unknown
- 1991-04-09 TW TW080102652A patent/TW199859B/zh active
- 1991-04-09 IL IL9780891A patent/IL97808A/en not_active IP Right Cessation
- 1991-04-09 KR KR1019910005643A patent/KR0165124B1/ko not_active IP Right Cessation
- 1991-04-09 EP EP91303088A patent/EP0452074B1/en not_active Expired - Lifetime
- 1991-04-09 PT PT97299A patent/PT97299B/pt not_active IP Right Cessation
- 1991-04-09 ES ES91303088T patent/ES2082923T3/es not_active Expired - Lifetime
- 1991-04-09 NZ NZ237753A patent/NZ237753A/xx unknown
- 1991-04-09 DK DK91303088.8T patent/DK0452074T3/da active
- 1991-04-09 CZ CS91990A patent/CZ279745B6/cs not_active IP Right Cessation
- 1991-04-09 AT AT91303088T patent/ATE133414T1/de not_active IP Right Cessation
- 1991-04-10 JP JP3077638A patent/JPH04224578A/ja active Pending
- 1991-04-10 FI FI911713A patent/FI96604C/fi active
- 1991-04-10 HU HU911165A patent/HU206113B/hu not_active IP Right Cessation
- 1991-04-10 CN CN91103069A patent/CN1038937C/zh not_active Expired - Fee Related
- 1991-04-10 IE IE120591A patent/IE72084B1/en not_active IP Right Cessation
- 1991-04-10 YU YU64691A patent/YU47809B/sh unknown
- 1991-04-10 RU SU914895120A patent/RU2002746C1/ru active
- 1991-04-10 AU AU74337/91A patent/AU634374B2/en not_active Ceased
- 1991-04-10 CA CA002040170A patent/CA2040170A1/en not_active Abandoned
- 1991-04-10 NO NO911398A patent/NO177709C/no not_active IP Right Cessation
-
1992
- 1992-04-20 RU SU925011387A patent/RU2086551C1/ru active
-
1996
- 1996-03-26 GR GR960400796T patent/GR3019416T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU64691A (sh) | Poboljšani ergolin-8-karboksamidi | |
ATE163648T1 (de) | Indole derivate als serotonin-antagonisten | |
FI910228A (fi) | Heteroaromatiska foereningar med fem ringatomer och substituerade med indol. | |
MY131298A (en) | 5-heteroyl indole derivatives | |
ATE236122T1 (de) | N-(2-substituierte-3-(2-aminoethyl)-1h-indol-5- yl)-amide als 5-ht1f agonisten | |
ATE273970T1 (de) | N-acyl und n-aroyl aralkylamide | |
EA200000561A1 (ru) | Триазиновые соединения для лечения расстройств цнс | |
EA200001104A1 (ru) | Аскорбат пароксетина | |
ATE256255T1 (de) | Grundplatte zum befestigen eines elements | |
EA200001105A1 (ru) | 10-камфорсульфонат пароксетина для лечения нарушений цнс | |
FR2453321A1 (fr) | Ressort a lames | |
ES2099786T3 (es) | Disposicion de fijacion de carriles. | |
FR2818747B1 (fr) | Procede de criblage base sur l'interaction siah-numb | |
ES2156868T3 (es) | Compuestos de arilalcoxifenoxi-imidazolina. | |
SE9201162D0 (sv) | Bullerskydd, saerskilt foer jaernvaegar och spaarvaegar | |
ITPS920010U1 (it) | Gruppo generatore di vibrazioni |